CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,162,329
- in 14 filings, $13.9M under 10b5-1 plans
Net −$59,162,329. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-08 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −2,536 | $592.43 | $1.5M | 26,301 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion | +2,500 | $272.70 | $682K | 28,801 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −1,811 | $592.40 | $1.1M | 26,990 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion | +2,250 | $272.70 | $614K | 29,240 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −1,630 | $592.43 | $966K | 27,610 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion | +2,250 | $272.70 | $614K | 29,860 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −1,630 | $592.43 | $966K | 28,230 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion | +1,500 | $272.70 | $409K | 29,730 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −1,086 | $592.43 | $643K | 28,644 |
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,500 | 15,500 | ||
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,500 | 12,000 | ||
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,500 | 9,500 | ||
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,250 | 7,250 | ||
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,250 | 5,000 | ||
| 2020-06-08 | Landry Robert E EVP Finance CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,500 | 3,500 | ||
| 2020-06-08 | GOLDSTEIN JOSEPH L Director | Exercise or conversion | +3,000 | $413.33 | $1.2M | 9,643 |
| 2020-06-08 | GOLDSTEIN JOSEPH L Director | Exercise or conversion | +3,000 | $413.33 | $1.2M | 12,643 |
| 2020-06-08 | GOLDSTEIN JOSEPH L Director | Exercise or conversion | +4,838 | $413.33 | $2.0M | 17,481 |
| 2020-06-08 | GOLDSTEIN JOSEPH L Director | Sale | −100 | $580.65 | $58K | 17,381 |
| 2020-06-08 | GOLDSTEIN JOSEPH L Director | Sale | −200 | $582.31 | $116K | 17,181 |
Page 145 of 181 · 3,603 trades